Development and evaluation of the hepaplate IPS: a high throughput organ-on-achip IPS hepatotoxicty screening platform
Ended Definitive Contract Awarded Last action
- Contract number
- HHSN271201800008C
- Awardee
-
Mimetas US Inc. UEI QGP7JLTGMAK9
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,500,000
Award facts
- Contract value 100% obligated
- $1,500,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 2 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
- Research
- SBIR Program Phase II Action
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $1,500,000 |
About this award
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences awarded a Small Business Innovation Research (SBIR) Phase II contract to Mimetas US, Inc., a self-certified small disadvantaged business, to develop and evaluate the HEPAPLATE IPS, a high-throughput organ-on-a-chip in vitro hepatotoxicity screening platform. The $1,500,000.00 firm fixed price contract was awarded on February 8, 2018, with a completion date of August 14, 2020. The work is being performed in Potomac, Maryland.
Quick answers
Who was awarded contract HHSN271201800008C?
HHSN271201800008C was awarded to Mimetas US Inc. by National Institute on Drug Abuse (National Institutes of Health) on February 8, 2018.
How much is contract HHSN271201800008C worth?
The government has obligated $1,500,000 on HHSN271201800008C.
Which agency awarded contract HHSN271201800008C?
National Institute on Drug Abuse (National Institutes of Health) awarded HHSN271201800008C, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Was contract HHSN271201800008C competed?
The extent of competition for HHSN271201800008C was full and open competition after exclusion of sources. The government received 2 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award